The New Drug Registration Guide - (second edition)(Chinese Edition) is a comprehensive resource designed to assist pharmaceutical professionals in navigating the drug registration process in China. This guide provides detailed information on regulatory requirements and best practices for new drug applications.

The price of the New Drug Registration Guide - (second edition)(Chinese Edition) is £170.45. This investment offers valuable insights and guidance for professionals looking to streamline the drug registration process in China.

Key features of the New Drug Registration Guide include comprehensive coverage of regulatory frameworks, practical tips for application submissions, and insights into market access strategies. Additionally, it includes case studies and examples to enhance understanding.

The New Drug Registration Guide is best suited for pharmaceutical companies, regulatory affairs professionals, and research institutions involved in drug development and registration in China. It serves as a vital tool for anyone needing to understand the complexities of the Chinese drug approval process.

To effectively use the New Drug Registration Guide, read through the chapters to familiarize yourself with the registration process and refer to specific sections as needed. Keeping the guide in a safe, dry place will help maintain its condition for future reference.